Search Results 951-960 of 17596 for Assay

1. Publications - Neal Niu, Ph.D. - Mayo Clinic

   Targeted gene approach with biochemical assay confirms ABCD1 mutation of X-linked adrenoleukodystrophy in a 62-year-old man with gait imbalance. Neuromuscul ...

2. Efficacy and Safety Study of bb2121 in Subjects With Relapsed and Refractory Multiple Myeloma (KarMMa) - Mayo Clinic

   Serum free light chain (FLC) assay: involved FLC level greater or equal to 10 mg/dL (100 mg/L) provided serum FLC ratio is abnormal. Recovery to Grade 1 or ...

3. HeadStart4: Newly Diagnosed Children (<10 y/o) With Medulloblastoma and Other CNS Embryonal Tumors - Mayo Clinic

   ... assays: all stages, age less than 6 years at diagnosis. Posterior fossa classic or anaplastic/large cell medulloblastoma with sufficient tumor material ...

4. A Study to Compare the Effectiveness and Safety of JCAR017 to Standard of Care in Adult Subjects With High-risk, Transplant-eligible Relapsed or Refractory Aggressive B-cell Non-Hodgkin Lymphomas - Mayo Clinic

   Subjects with negative polymerase chain reaction (PCR) assay for viral load for hepatitis B or C are permitted. Subjects positive for hepatitis B surface ...

5. A Study to Evaluate the Effectiveness, Safety, and Tolerability of BOS-589 in the Treatment of Patients with Diarrhea-predominant Irritable Bowel Syndrome (IBS-D) - Mayo Clinic

   Patients with a positive HCV antibody at screening may be eligible if confirmatory testing (i.e., Recombinant Immunoblot Assay [RIBA], or HCV RNA viral load) ...

6. Safety Study of OA-235i in Subjects With Nonalcoholic Steatohepatitis - Mayo Clinic

   ... assays in adult subjects with suspected or confirmed diagnosis of noncirrhotic NASH with no fibrosis to moderate fibrosis (stages F0-F2) and correlate PD ...

7. A Study to Evaluate Lenalidomide and Dexamethasone, with or without Daratumumab, in Treating High-Risk Smoldering Myeloma Patients - Mayo Clinic

   Abnormal serum free light chain (FLC) ratio of involved to uninvolved >20, but less than 100 if the involved FLC is >10 mg/dL by serum FLC assay;; Serum M ...

8. A Study to Analyze Whole Methylome for Identification of Epigenetic Variations in Undiagnosed Congenital Disorders - Mayo Clinic

   Examples of “equivocal” results include: borderline hypo- or hypermethylation on a previous targeted methylation assay such as methylation-sensitive MLPA ...

9. A Study to Evaluate Androgen-Deprivation Therapy and Radiation Therapy in Treating Patients With Prostate Cancer - Mayo Clinic

   Baseline serum PSA value performed with an FDA-approved assay (e.g., Abbott, Hybritech) within 120 days prior to registration. Study entry PSA should not be ...

10. Light Chain Amyloidosis Maintenance Evaluation - Mayo Clinic

    Patients must have monoclonal protein studies (serum free light chain assay, serum immunofixation or serum MASS-FIX) obtained at time of diagnosis before ...